Sub-Tenon injection of mitomycin C may have advantages over sponge application

Sub-Tenon injection of mitomycin C may be an alternative to conventional application of MMC with sponges, according to a study.
The use of antimetabolites to prevent excessive postoperative scarring and reduce the risk for failure has become standard in glaucoma surgery. Since its first application in 1992, MMC has significantly improved the success rate of trabeculectomy. However, MMC has several potential toxicity-related side effects. Different concentrations and exposure times have therefore been tested to find the right balance between safety and efficacy.
In a prospective, randomized,